Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulphate for fetal neuroprotection in very preterm birth risk
ACTRN12606000252516Phase 3Completed
- Sponsor
- Caroline Crowther
- Start
- Feb 1996
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in preterm birth and cerebral palsy (CP) comparing Magnesium sulphate with Placebo (2 arms). Primary endpoints: Cerebral palsy, Neonatal infant survival and 1 more. Started Feb 1996; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
preterm birthcerebral palsy (CP)
Beyond the preview
Go deeper on ACTRN12606000252516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000252516.